Skip to main content

Antiplatelet Therapy in Pediatric Cardiovascular Patients

Abstract

Platelets play a critical role in normal physiologic processes such as hemostasis, wound healing, inflammation, and innate immunity. However, they also play a role in the pathologic process of thrombosis. Although antiplatelet therapy is most commonly used to prevent thrombotic events for adults with atherosclerotic vascular disease, children with certain types of congenital heart disease, stroke, and Kawasaki disease also are at risk for thrombosis and may benefit from antiplatelet therapy. Unfortunately, very little data on the efficacy and safety of antiplatelet therapy for pediatric patients are available. As a consequence, consistent clinical practice among pediatric practitioners is lacking. Furthermore, much of what is practiced results from extrapolation from adult studies, which may be problematic because many aspects of platelet biology differ between children and adults. This review discusses aspects of antiplatelet therapy for pediatric patients.

This is a preview of subscription content, access via your institution.

References

  1. Al Jubair KA, Al Fagih MR, Al Jarallah AS, Al Yousef S, Ali Khan MA, Ashmeg A, Al Faraidi Y, Sawyer W (1998) Results of 546 Blalock-Taussig shunts performed in 478 patients. Cardiol Young 8:486–490

    Article  CAS  PubMed  Google Scholar 

  2. Bernard TJ, Goldenberg NA (2008) Pediatric arterial ischemic stroke. Pediatr Clin North Am 55:323–338, viii

    Article  PubMed  Google Scholar 

  3. Bhutta AT, Van Savell H, Schexnayder SM (2003) Reye’s syndrome: down but not out. South Med J 96:43–45

    Article  PubMed  Google Scholar 

  4. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48:e1–e148

    Article  PubMed  Google Scholar 

  5. Bradley SM, Sade RM, Crawford FA Jr, Stroud MR (1997) Anticoagulation in children with mechanical valve prostheses. Ann Thorac Surg 64:30–34; discussion 35–36

    Article  CAS  PubMed  Google Scholar 

  6. Carcao MD, Blanchette VS, Dean JA, He L, Kern MA, Stain AM, Sparling CR, Stephens D, Ryan G, Freedman J, Rand ML (1998) The platelet function analyzer (PFA-100): a novel in vitro system for evaluation of primary haemostasis in children. Br J Haematol 101:70–73

    Article  CAS  PubMed  Google Scholar 

  7. Centazzo S, Montigny M, Davignon A, Chartrand C, Fournier A, Marchand T (1993) Use of acetylsalicylic acid to improve patency of subclavian to pulmonary artery Gore-Tex shunts. Can J Cardiol 9:243–246

    CAS  PubMed  Google Scholar 

  8. Costello I, Wong IC, Nunn AJ (2004) A literature review to identify interventions to improve the use of medicines in children. Child Care Health Dev 30:647–665

    Article  CAS  PubMed  Google Scholar 

  9. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ (2004) Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364:331–337

    Article  CAS  PubMed  Google Scholar 

  10. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057–1061

    CAS  PubMed  Google Scholar 

  11. Ebeid MR, Prieto LR, Latson LA (1997) Use of balloon-expandable stents for coarctation of the aorta: initial results and intermediate-term follow-up. J Am Coll Cardiol 30:1847–1852

    Article  CAS  PubMed  Google Scholar 

  12. Etheridge SP, Tani LY, Minich LL, Revenaugh JR (1998) Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease. Cathet Cardiovasc Diagn 45:264–268

    Article  CAS  PubMed  Google Scholar 

  13. Fenton KN, Siewers RD, Rebovich B, Pigula FA (2003) Interim mortality in infants with systemic-to-pulmonary artery shunts. Ann Thorac Surg 76:152–156; discussion 156–157

    Article  PubMed  Google Scholar 

  14. Finkelstein Y, Nurmohamed L, Avner M, Benson LN, Koren G (2005) Clopidogrel use in children. J Pediatr 147:657–661

    Article  CAS  PubMed  Google Scholar 

  15. Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH (2003) Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single-centre study in 236 consecutive patients. Heart 89:199–204

    Article  CAS  PubMed  Google Scholar 

  16. Fu YC, Hijazi ZM (2008) The Amplatzer Septal Occluder, a transcatheter device for atrial septal defect closure. Expert Rev Med Devices 5:25–31

    Article  PubMed  Google Scholar 

  17. Fullerton HJ, Wu YW, Sidney S, Johnston SC (2007) Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics 119:495–501

    Article  PubMed  Google Scholar 

  18. Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schunemann HJ (2008) Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133:123S–131S

    Article  PubMed  Google Scholar 

  19. Hirsh J, Guyatt G, Albers GW, Harrington R, Schunemann HJ (2008) Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed). Chest 133:71S–109S

    Article  PubMed  Google Scholar 

  20. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202–207

    Article  CAS  PubMed  Google Scholar 

  21. Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM (2004) Treatment of acute Kawasaki disease: aspirin’s role in the febrile stage revisited. Pediatrics 114:e689–e693

    Article  PubMed  Google Scholar 

  22. Hurwitz ES, Barrett MJ, Bregman D, Gunn WJ, Pinsky P, Schonberger LB, Drage JS, Kaslow RA, Burlington DB, Quinnan GV et al (1987) Public Health Service study of Reye’s syndrome and medications: report of the main study. JAMA 257:1905–1911

    Article  CAS  PubMed  Google Scholar 

  23. Israels SJ, Cheang T, McMillan-Ward EM, Cheang M (2001) Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr 138:116–119

    Article  CAS  PubMed  Google Scholar 

  24. Israels SJ, Daniels M, McMillan EM (1990) Deficient collagen-induced activation in the newborn platelet. Pediatr Res 27:337–343

    Article  CAS  PubMed  Google Scholar 

  25. Jacobs ML, Pourmoghadam KK, Geary EM, Reyes AT, Madan N, McGrath LB, Moore JW (2002) Fontan’s operation: Is aspirin enough? Is Coumadin too much? Ann Thorac Surg 73:64–68

    Article  PubMed  Google Scholar 

  26. Jurk K, Kehrel BE (2005) Platelets: physiology and biochemistry. Semin Thromb Hemost 31:381–392

    Article  CAS  PubMed  Google Scholar 

  27. Khitin LM, Sade RM, Bradley SM, Crawford FA Jr, Widener CE, Stroud MR (2006) Prevention of thrombosis and embolism in children and adolescents with mechanical valve prostheses: warfarin versus antiplatelet agents. J Heart Valve Dis 15:394–399; discussion 399

    PubMed  Google Scholar 

  28. Kutty S, Zahn EM (2008) Interventional therapy for neonates with critical congenital heart disease. Catheter Cardiovasc Interv 72:663–674

    Article  PubMed  Google Scholar 

  29. Lammers AE, Derrick G, Haworth SG, Bonhoeffer P, Yates R (2007) Efficacy and long-term patency of fenestrated Amplatzer devices in children. Catheter Cardiovasc Interv 70:578–584

    Article  PubMed  Google Scholar 

  30. LeBlanc JG, Sett SS, Vince DJ (1993) Antiplatelet therapy in children with left-sided mechanical prostheses. Eur J Cardiothorac Surg 7:211–215

    Article  CAS  PubMed  Google Scholar 

  31. Li JS, Yow E, Berezny KY, Bokesch PM, Takahashi M, Graham TP Jr, Sanders SP, Sidi D, Bonnet D, Ewert P, Jennings LK, Michelson AD (2008) Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) trial. Circulation 117:553–559

    Article  CAS  PubMed  Google Scholar 

  32. Li JS, Yow E, Berezny KY, Rhodes JF, Bokesch PM, Charpie JR, Forbus GA, Mahony L, Boshkov L, Lambert V, Bonnet D, Michel-Behnke I, Graham TP, Takahashi M, Jaggers J, Califf RM, Rakhit A, Fontecave S, Sanders SP (2007) Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: Does aspirin make a difference? Circulation 116:293–297

    Article  PubMed  Google Scholar 

  33. Madan M, Berkowitz SD, Tcheng JE (1998) Glycoprotein IIb/IIIa integrin blockade. Circulation 98:2629–2635

    CAS  PubMed  Google Scholar 

  34. Maltz LA, Gauvreau K, Connor JA, Jenkins KJ (2008) Clopidogrel in a pediatric population: safety and efficacy results from a single center. Pediatr Cardiol 30:99–105

    Article  PubMed  Google Scholar 

  35. Matsui DM (1997) Drug compliance in pediatrics: clinical and research issues. Pediatr Clin North Am 44:1–14

    Article  CAS  PubMed  Google Scholar 

  36. Menon SC, Cetta F, Dearani JA, Burkhart HA, Cabalka AK, Hagler DJ (2008) Hybrid intraoperative pulmonary artery stent placement for congenital heart disease. Am J Cardiol 102:1737–1741

    Article  PubMed  Google Scholar 

  37. Mertens L, Eyskens B, Boshoff D, Gewillig M (2008) Safety and efficacy of clopidogrel in children with heart disease. J Pediatr 153:61–64

    Article  CAS  PubMed  Google Scholar 

  38. Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P, Michelson AD (2008) Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed). Chest 133(Suppl):887S–968S

    Article  CAS  PubMed  Google Scholar 

  39. Monagle P, Cochrane A, Robberts R, Szechtman B, Gent M, Andrew M, McCrindle B (2008) Abstract 1157: a multicentre randomized trial comparing heparin/warfarin versus aspirin as primary thromboprophylaxis for two years after Fontan procedure in children. Circulation 118(18 Suppl):651

    Google Scholar 

  40. Monagle P, Karl TR (2002) Thromboembolic problems after the Fontan operation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5:36–47

    Article  PubMed  Google Scholar 

  41. Motz R, Wessel A, Ruschewski W, Bursch J (1999) Reduced frequency of occlusion of aortopulmonary shunts in infants receiving aspirin. Cardiol Young 9:474–477

    Article  CAS  PubMed  Google Scholar 

  42. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733

    Article  PubMed  Google Scholar 

  43. Paediatric Stroke Working Group Stroke in Childhood (2004) clinical guidelines for diagnosis, management and rehabilitation. Retrieved 19 May 2008 at http://www.rcplondon.ac.uk/pubs/books/childstroke/childstroke_guidelines.pdf

  44. Patrono C, Bachmann F, Baigent C, Bode C, De Caterina R, Charbonnier B, Fitzgerald D, Hirsh J, Husted S, Kvasnicka J, Montalescot G, Garcia Rodriguez LA, Verheugt F, Vermylen J, Wallentin L, Priori SG, Alonso Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernandez Burgos E, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Ferreira R, Steg PG, Teixeira F, Wilcox R (2004) Expert consensus document on the use of antiplatelet agents. Task Force on the Use of Antiplatelet Agents in Patients With Atherosclerotic Cardiovascular Disease of the European Society of Cardiology. Eur Heart J 25:166–181

    Article  PubMed  Google Scholar 

  45. Rajasekhar D, Barnard MR, Bednarek FJ, Michelson AD (1997) Platelet hyporeactivity in very-low-birth-weight neonates. Thromb Haemost 77:1002–1007

    CAS  PubMed  Google Scholar 

  46. Rajasekhar D, Kestin AS, Bednarek FJ, Ellis PA, Barnard MR, Michelson AD (1994) Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 72:957–963

    CAS  PubMed  Google Scholar 

  47. Rao PS, Solymar L, Mardini MK, Fawzy ME, Guinn G (1989) Anticoagulant therapy in children with prosthetic valves. Ann Thorac Surg 47:589–592

    CAS  PubMed  Google Scholar 

  48. Roschitz B, Sudi K, Kostenberger M, Muntean W (2001) Shorter PFA-100 closure times in neonates than in adults: role of red cells, white cells, platelets, and von Willebrand factor. Acta Paediatr 90:664–670

    Article  CAS  PubMed  Google Scholar 

  49. Roy P, Bonello L, Torguson R, de Labriolle A, Lemesle G, Pinto Slottow TL, Steinberg DH, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R (2008) Impact of “nuisance” bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Am J Cardiol 102:1614–1617

    Article  PubMed  Google Scholar 

  50. Salem DN, O’Gara PT, Madias C, Pauker SG (2008) Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:593S–629S

    Article  PubMed  Google Scholar 

  51. Sanofi-Aventis and Bristol-Myers Squibb (2010) Efficacy and safety of clopidogrel in neonates/infants with systemic to pulmonary artery shunt palliation (CLARINET). Retrieved 2 January 2010 at http://clinicaltrials.gov/ct2/show/NCT00396877

  52. Saulsbury FT (2002) Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome. Clin Pediatr Philadelphia 41:597–601

    Article  Google Scholar 

  53. Schror K (2007) Aspirin and Reye syndrome: a review of the evidence. Paediatr Drugs 9:195–204

    Article  PubMed  Google Scholar 

  54. Seipelt RG, Franke A, Vazquez-Jimenez JF, Hanrath P, von Bernuth G, Messmer BJ, Muhler EG (2002) Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches. Ann Thorac Surg 74:556–562

    Article  PubMed  Google Scholar 

  55. Serra AJ, McNicholas KW, Olivier HF Jr, Boe SL, Lemole GM (1987) The choice of anticoagulation in pediatric patients with the St. Jude Medical valve prostheses. J Cardiovasc Surg Torino 28:588–591

    CAS  PubMed  Google Scholar 

  56. Soman T, Rafay MF, Hune S, Allen A, MacGregor D, deVeber G (2006) The risks and safety of clopidogrel in pediatric arterial ischemic stroke. Stroke 37:1120–1122

    Article  CAS  PubMed  Google Scholar 

  57. Strater R, Kurnik K, Heller C, Schobess R, Luigs P, Nowak-Gottl U (2001) Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke 32:2554–2558

    Article  CAS  PubMed  Google Scholar 

  58. Studer MA, Kennedy CE, Dreyer WJ, Price JF, Moffett BS, Teitel ER, Carberry KE, Morales DL, McKenzie ED, Chang AC (2006) An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent. J Heart Lung Transplant 25:857–861

    Article  PubMed  Google Scholar 

  59. Terai M, Shulman ST (1997) Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 131:888–893

    Article  CAS  PubMed  Google Scholar 

  60. Turkoski BB (2007) Medicating young or very young patients: part I. Orthop Nurs 26:134–137; quiz 138–139

    Article  PubMed  Google Scholar 

  61. University of Rochester, University of Miami, Bayer and National Institute of Neurological Disorders and Stroke (NINDS) (2007, March 14) Aspirin prophylaxis in sickle cell disease. Retrieved 2 January 2010 at http://clinicaltrials.gov/ct2/show/NCT00178464

  62. Verrier ED, Tranbaugh RF, Soifer SJ, Yee ES, Turley K, Ebert PA (1986) Aspirin anticoagulation in children with mechanical aortic valves. J Thorac Cardiovasc Surg 92:1013–1020

    CAS  PubMed  Google Scholar 

  63. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsen M (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045–1057

    Article  CAS  PubMed  Google Scholar 

  64. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD (2008) ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 118:e714–e833

    Article  PubMed  Google Scholar 

  65. Weinstein GS, Mavroudis C, Ebert PA (1982) Preliminary experience with aspirin for anticoagulation in children with prosthetic cardiac valves. Ann Thorac Surg 33:549–553

    CAS  PubMed  Article  Google Scholar 

  66. Williams RV, Wilke VM, Tani LY, Minich LL (2002) Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics 109:E4

    Article  PubMed  Google Scholar 

  67. Winnick S, Lucas DO, Hartman AL, Toll D (2005) How do you improve compliance? Pediatrics 115:e718–e724

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This article was written and edited by the authors, who take full responsibility for its content. Editorial assistance with searching the literature, coordinating revisions, and creating tables in the preparation of this articlet was provided by Melanie Leiby, PhD, of Wolters Kluwer, and funded by Sanofi-Aventis and Bristol-Myers Squibb, Inc. The authors did not receive any compensation for this work.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jennifer S. Li.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Li, J.S., Newburger, J.W. Antiplatelet Therapy in Pediatric Cardiovascular Patients. Pediatr Cardiol 31, 454–461 (2010). https://doi.org/10.1007/s00246-010-9672-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-010-9672-2

Keywords

  • Antiplatelet therapy
  • Congenital cardiac defects
  • Kawasaki disease
  • Pediatric
  • Stroke